CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
57
Frequently Asked Questions
What is Market Cap of CollPlant Biotechnologies Ltd - Ordinary Shares New?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. CollPlant Biotechnologies Ltd - Ordinary Shares New market cap is $34.46M.
What is the 52-week high for CollPlant Biotechnologies Ltd - Ordinary Shares New?
52 week high is the highest price of a stock in the past 52 weeks, or one year. CollPlant Biotechnologies Ltd - Ordinary Shares New 52 week high is $5.01 as of September 12, 2025.
What is the 52-week low for CollPlant Biotechnologies Ltd - Ordinary Shares New?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. CollPlant Biotechnologies Ltd - Ordinary Shares New 52 week low is $1.31 as of September 12, 2025.
What is CollPlant Biotechnologies Ltd - Ordinary Shares New stock price today?
CollPlant Biotechnologies Ltd - Ordinary Shares New stock price today is $2.70.
What was CollPlant Biotechnologies Ltd - Ordinary Shares New stock price yesterday?
CollPlant Biotechnologies Ltd - Ordinary Shares New stock price yesterday was $2.71.
What is the PE ratio of CollPlant Biotechnologies Ltd - Ordinary Shares New?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. CollPlant Biotechnologies Ltd - Ordinary Shares New’s P/E ratio is -2.41.
What is the Price-to-Book ratio of CollPlant Biotechnologies Ltd - Ordinary Shares New?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. CollPlant Biotechnologies Ltd - Ordinary Shares New P/B ratio is 2.7557.
What is the 50-day moving average of CollPlant Biotechnologies Ltd - Ordinary Shares New?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. CollPlant Biotechnologies Ltd - Ordinary Shares New 50-day moving average is $2.33.
How many employess does CollPlant Biotechnologies Ltd - Ordinary Shares New has?
CollPlant Biotechnologies Ltd - Ordinary Shares New has 57 employees.
